News

NurExone Expands European Engagement with Investor Events in Germany and Switzerland
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system ...
Excellon Announces Transfer of Listing to TSX Venture Exchange
Excellon Resources Inc. (TSX: EXN) (FSE: E4X2) ("Excellon" or the "Company") is pleased to announce that, further to the Company's news release dated April 15, 2025, it has received approval to ...
Exclusive: Europe to hand billions in frozen Russian cash to Western investors, sources say
Euroclear plans to seize and redistribute about 3 billion euros ($3.4 billion) of Russia's funds that are frozen at the ...